Ghattas Jinane, Gorasso Vanessa, De Pauw Robby, Thunus Sophie, Speybroeck Niko, Devleesschauwer Brecht
Institute of Health and Society (IRSS), Université Catholique de Louvain, Brussels, Belgium.
Lifestyle and Chronic Diseases, Department of Epidemiology and Public Health, Rue Juliette Wytsmanstraat 14, 1050, Sciensano Brussels, Belgium.
Arch Public Health. 2022 Oct 18;80(1):222. doi: 10.1186/s13690-022-00976-2.
In a context of decreasing resources and growing health needs, evidence-based health and care policies are essential. This study aims to assess the health trends in Belgium between 1990 and 2019, to compare the Belgian health status to that of the EU-15 countries, and to identify the main drivers in trends over time and country differences within the EU-15.
We extracted estimates from the GBD 2019 study via the GBD results tool and visualization tools. We compared the Belgian health status with 14 European Union comparator countries between 1990 and 2019, and decomposed the time trends and country differences into the unique contributions of the different underlying causes of death and disability.
Life expectancy (LE) in Belgium improved significantly between 1990 and 2019 for both men and women. Belgium age-standardised mortality rates dropped significantly for men (-40%) and women (-33%) between 1990 and 2019. Overall, Belgium age-standardised disability-adjusted life year (DALY) rates dropped by 23%. This decrease is mainly due to decreasing trends in age-standardised years of life lost (YLL) rates while age-standardised years lived with disability (YLD) rates remained stable. Compared to EU-15, Belgium's ranking in terms of age-standardised DALY rates worsened for both men and women in 2019. Self-harm and falls are major causes of disease burden, with DALY rates that are higher than in many other EU-15 countries, indicating a realistic potential for improvement. Lung cancer DALY rates remain worrisome for men, and even show an increasing trend for women. Increasing trends of headache disorders, drug use disorders, and diabetes, require further attention.
Non-communicable diseases remain the main contributors for health burden in Belgium, with disability accounting for an increasingly larger share of the disease burden. Despite considerable improvements, Belgium's ranking for DALYs decreased between 1990 and 2019 compared to the EU-15. This study identified priority causes of disease burden based on their contributions to current evolutions and EU-15 differences. Since many of these causes are considered to be avoidable, primary and secondary prevention are crucial elements for reducing the burden of disease on the healthcare system.
在资源减少而健康需求不断增长的背景下,基于证据的健康与护理政策至关重要。本研究旨在评估1990年至2019年比利时的健康趋势,将比利时的健康状况与欧盟15国进行比较,并确定欧盟15国内随时间变化的趋势以及国家间差异的主要驱动因素。
我们通过全球疾病负担(GBD)结果工具和可视化工具从GBD 2019研究中提取了估计数据。我们比较了1990年至2019年比利时与14个欧盟对照国家的健康状况,并将时间趋势和国家间差异分解为不同潜在死亡和残疾原因的独特贡献。
1990年至2019年期间,比利时男性和女性的预期寿命均显著提高。1990年至2019年期间,比利时男性(-40%)和女性(-33%)的年龄标准化死亡率显著下降。总体而言,比利时年龄标准化伤残调整生命年(DALY)率下降了23%。这一下降主要归因于年龄标准化生命损失年(YLL)率的下降趋势,而年龄标准化残疾生存年(YLD)率保持稳定。与欧盟15国相比,2019年比利时在年龄标准化DALY率方面男性和女性的排名均有所恶化。自我伤害和跌倒仍是疾病负担的主要原因,其DALY率高于许多其他欧盟15国,表明有切实的改善潜力。男性肺癌的DALY率仍然令人担忧,女性甚至呈上升趋势。头痛疾病、药物使用障碍和糖尿病的上升趋势需要进一步关注。
非传染性疾病仍然是比利时健康负担的主要贡献因素,残疾在疾病负担中所占比例越来越大。尽管有显著改善,但与欧盟15国相比,比利时在1990年至2019年期间DALY的排名有所下降。本研究根据疾病负担对当前演变和欧盟15国差异的贡献确定了优先病因。由于其中许多病因被认为是可以避免的,一级和二级预防是减轻医疗系统疾病负担的关键要素。